APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $279 | -8.8% | 7,341 | +119.7% | 0.00% | 0.0% |
| Q2 2023 | $306 | +9.3% | 3,341 | -21.1% | 0.00% | 0.0% |
| Q1 2023 | $280 | +19.1% | 4,232 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $235 | -99.9% | 4,518 | +10.5% | 0.00% | 0.0% |
| Q3 2022 | $278,000 | +64.5% | 4,088 | +9.5% | 0.00% | – |
| Q2 2022 | $169,000 | -16.3% | 3,734 | 0.0% | 0.00% | – |
| Q1 2022 | $202,000 | +32.9% | 3,734 | +15.5% | 0.00% | – |
| Q4 2021 | $152,000 | +42.1% | 3,234 | 0.0% | 0.00% | – |
| Q3 2021 | $107,000 | -47.5% | 3,234 | 0.0% | 0.00% | – |
| Q2 2021 | $204,000 | +19.3% | 3,234 | -19.6% | 0.00% | – |
| Q1 2021 | $171,000 | -25.3% | 4,022 | 0.0% | 0.00% | – |
| Q4 2020 | $229,000 | +89.3% | 4,022 | 0.0% | 0.00% | – |
| Q3 2020 | $121,000 | -66.1% | 4,022 | -63.4% | 0.00% | -100.0% |
| Q2 2020 | $357,000 | +389.0% | 10,984 | +300.6% | 0.00% | – |
| Q1 2020 | $73,000 | -12.0% | 2,742 | 0.0% | 0.00% | – |
| Q4 2019 | $83,000 | -45.4% | 2,742 | -54.3% | 0.00% | – |
| Q2 2019 | $152,000 | +29.9% | 6,005 | 0.0% | 0.00% | – |
| Q1 2019 | $117,000 | +53.9% | 6,005 | 0.0% | 0.00% | – |
| Q4 2018 | $76,000 | -29.0% | 6,005 | 0.0% | 0.00% | – |
| Q3 2018 | $107,000 | – | 6,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |